The intensity of HK2-positive staining and the number of cells that have subcellular co-localization of HK2 and NOX2 were elevated in patients with GBM (G4) and G3 glioma relative to those in patients with low-grade glioma (G1, G2) (Figure 4d,e). This evidence concerns the gene HK2 and central nervous system cancer.